Chelsea Therapeutics
13:26 :
Chelsea Therapeutics soars on FDA nod -
BOSTON (MarketWatch) -- Shares of Chelsea Therapeutics shares soared 61% to $3.88 on Friday, the day after an advisory panel for the U.S. Food and Drug Administration recommended approval of Chelsea's neurological drug Northera. ...
11:51 :
Chelsea Therapeutics jumps 8% on ADHD study -
BOSTON (MarketWatch) -- Shares of Chelsea Therapeutics jumped 8% to $5.50 on Tuesday, after the biotech group reported positive preliminary data from a Phase II clinical study for its drug droxidopa in the treatment of adults ...
09:17 :
Chelsea Therapeutics soars on price target upgrade -
BOSTON (MarketWatch) -- Chelsea Therapeutics shares soared early Friday after analysts at Roth Capital tripled their price target of the stock to $18. The upgrade comes the day after the biotech firm announced positive Phase ...
actualidad Chelsea Therapeutics -